29 Jun
2020
16:30 E.S.T.

Cellectis S.A. Reports Results from Annual Shareholders’ General Meeting Held on June 29, 2020

Read more

25 Jun
2020
16:30 E.S.T.

Cellectis Published Streamlined Manufacturing Method to Generate Ultrapure Allogeneic CAR T-Cell Therapies

Read more

18 May
2020
16:30 E.S.T.

Cellectis Appoints Biopharma Veteran Leopold Bertea as Senior Vice President of Technical Operations - Europe

Read more

11 May
2020
16:30 E.S.T.

Cellectis’ Annual Shareholders’ General Meeting to be Held on June 29, 2020

Read more

06 May
2020
16:30 E.S.T.

Cellectis Provides Business Update and Reports Financial Results for First Quarter 2020

Read more

29 Apr
2020
16:30 E.S.T.

Cellectis to Hold First Quarter 2020 Earnings Call on Thursday, May 7, 2020 at 7:30 AM EDT

Read more

13 Apr
2020
16:30 E.S.T.

Cellectis Appoints Carrie Brownstein, M.D., as Chief Medical Officer

Read more

10 Mar
2020
16:30 E.S.T.

US Patent Covering CRISPR-Edited Allogeneic CAR T-Cells Granted to Cellectis

Read more

04 Mar
2020
16:30 E.S.T.

Cellectis Provides Business Update and Reports 4th Quarter and Full Year 2019 Financial Results

Read more

04 Mar
2020
16:05 E.S.T.

Cellectis and Servier Execute the Amendment Confirming the Expansion of their Collaboration on UCART19 Products

Read more